Expression of v-src induces a myeloproliferative disease in bone-marrow-reconstituted mice.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 2568314)

Published in Genes Dev on June 01, 1989

Authors

G Keller1, E F Wagner

Author Affiliations

1: Basel Institute for Immunology, Switzerland.

Articles by these authors

(truncated to the top 100)

Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature (1988) 13.21

Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (1985) 7.54

c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (1994) 5.97

Strain-dependent epithelial defects in mice lacking the EGF receptor. Science (1995) 5.22

Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature (1997) 5.08

Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev (1995) 4.54

Bone and haematopoietic defects in mice lacking c-fos. Nature (1993) 4.07

AP-1 in mouse development and tumorigenesis. Oncogene (2001) 3.93

Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell (1994) 3.91

Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68

Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev (1999) 3.51

c-jun is essential for normal mouse development and hepatogenesis. Nature (1993) 3.43

Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet (1999) 3.42

Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol (1999) 3.29

PARP is important for genomic stability but dispensable in apoptosis. Genes Dev (1997) 3.20

The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. Proc Natl Acad Sci U S A (1981) 2.93

Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell (1990) 2.77

Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J Am Acad Child Adolesc Psychiatry (1996) 2.69

Transfer of genes into embryonal carcinoma cells by retrovirus infection: efficient expression from an internal promoter. EMBO J (1985) 2.60

JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol (1999) 2.60

Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56

Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development (2000) 2.43

Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med (2000) 2.36

Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell (1988) 2.36

Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature (1984) 2.34

Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J (2001) 2.32

The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell (2000) 2.22

Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO J (1987) 2.16

Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell (1989) 2.14

Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J (1985) 2.11

A universal retroviral vector for efficient constitutive expression of exogenous genes. Nucleic Acids Res (1987) 2.11

The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res (1996) 2.09

Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (1987) 2.08

The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat Med (1997) 2.07

JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J (2000) 2.05

Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature (1994) 2.03

Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med (1999) 1.98

Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet (2000) 1.96

A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J (1998) 1.86

Functions of c-Jun in liver and heart development. J Cell Biol (1999) 1.85

The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell (2000) 1.81

c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med (2001) 1.81

Clustered homeo boxes are differentially expressed during murine development. Cell (1985) 1.80

Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell (2001) 1.79

Fos is an essential component of the mammalian UV response. EMBO J (1995) 1.73

Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J (1997) 1.70

Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol (1993) 1.70

Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech Dev (1997) 1.69

Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors. Arch Gen Psychiatry (1991) 1.65

Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J (1994) 1.64

Prenatal lethalities in mice homozygous for human growth hormone gene sequences integrated in the germ line. Cell (1983) 1.63

Introduction of a viral thymidine kinase gene and the human beta-globin gene into developmentally multipotential mouse teratocarcinoma cells. Proc Natl Acad Sci U S A (1980) 1.58

JunB is essential for mammalian placentation. EMBO J (1999) 1.57

Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem (1995) 1.56

Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nat Genet (1997) 1.52

Inducible and tissue-specific expression of human C-reactive protein in transgenic mice. EMBO J (1987) 1.51

Expression of foreign genes from retroviral vectors in mouse teratocarcinoma chimaeras. EMBO J (1985) 1.48

Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ (1995) 1.46

Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol (1990) 1.46

A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J (1991) 1.46

Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene (2000) 1.45

c-fos expression induces bone tumors in transgenic mice. Oncogene (1989) 1.40

Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. Development (2001) 1.38

c-fos expression interferes with thymus development in transgenic mice. Cell (1988) 1.35

Placental vascularisation requires the AP-1 component fra1. Development (2000) 1.34

Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev (2000) 1.33

Gene transfer into murine stem cells and mice using retroviral vectors. Cold Spring Harb Symp Quant Biol (1985) 1.27

Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc Natl Acad Sci U S A (1990) 1.24

c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. Cancer Res (1995) 1.24

Early fetal hematopoietic development from in vitro differentiated embryonic stem cells. New Biol (1991) 1.23

Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice. Am J Pathol (1993) 1.22

Transfer of nonselectable genes into mouse teratocarcinoma cells and transcription of the transferred human beta-globin gene. Mol Cell Biol (1982) 1.19

Protective role of Raf-1 in Salmonella-induced macrophage apoptosis. J Exp Med (2001) 1.19

c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol Cell Biol (2000) 1.18

Control of phosphoenolpyruvate-dependent phosphotransferase-mediated sugar transport in Escherichia coli by energization of the cell membrane. Proc Natl Acad Sci U S A (1979) 1.16

Expression of human alpha 1-acid glycoprotein genes in cultured cells and in transgenic mice. Genes Dev (1988) 1.15

Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Neoplasia (2001) 1.14

Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol Cell Biol (1992) 1.14

Expression of functional human EGF receptor on murine bone marrow cells. EMBO J (1988) 1.13

Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene (1995) 1.09

Jun and JunD-dependent functions in cell proliferation and stress response. Cell Death Differ (2010) 1.09

Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration. J Cell Biol (2000) 1.08

Oncogenic properties of the middle T antigens of polyomaviruses. Adv Cancer Res (1994) 1.07

Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol Cell Biol (1994) 1.06

Development of Escherichia coli virus T1. The role of the proton-motive force. J Biol Chem (1980) 1.05

Antagonistic control of cell fates by JNK and p38-MAPK signaling. Cell Death Differ (2007) 1.04

The role of the transcription factor AP-1 in colitis-associated and beta-catenin-dependent intestinal tumorigenesis in mice. Oncogene (2008) 1.03

Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase. Oncogene (1997) 1.03

Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity. Oncogene (1992) 1.01

Human beta-globin gene sequences injected into mouse eggs, retained in adults, and transmitted to progeny. Science (1982) 1.01

Expression of v-src induces aberrant development and twinning in chimaeric mice. Development (1991) 1.01

Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). Proc Natl Acad Sci U S A (2001) 1.00

Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet (1995) 0.98

Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice. Blood (2000) 0.98

Degeneration of neural cells in the central nervous system of mice deficient in the gene for the adhesion molecule on Glia, the beta 2 subunit of murine Na,K-ATPase. J Cell Biol (1994) 0.98

Expression of human foamy virus is differentially regulated during development in transgenic mice. New Biol (1992) 0.97

Human foamy virus: an underestimated neuropathogen? Brain Pathol (1992) 0.97

Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation. Oncogene (2011) 0.96

Generation of normal T and B lymphocytes by c-jun deficient embryonic stem cells. Immunity (1994) 0.96

Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE. Bone (2000) 0.96